FMP
NASDAQ
10.54 USD
-0.3 (-2.85%)
Mr. Matthew Gline
Healthcare
Biotechnology
https://roivant.com
NASDAQ
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
0001635088
BMG762791017
G76279101
11-12 St. James’s Square
44 2074 003 347
GB
904
Dec 8, 2020
0001635088
NASDAQ
Biotechnology
Healthcare
G76279101
BMG762791017
GB
10.54
1.37
5.71M
8.49B
-
6.97-13.24
-3.69
-
-
-
-
2
-
https://roivant.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.